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Abstract
Background: Colorectal cancer screening rates are low among poor and disadvantaged patients.
Patient navigation has been shown to increase breast and cervical cancer screening rates, but few
studies have looked at the potential of patient navigation to increase colorectal cancer screening
rates.
Methods: The objective was to determine the feasibility and effectiveness of a patient navigator-
based intervention to increase colorectal cancer screening rates in community health centers.
Patients at the intervention health center who had not been screened for colorectal cancer and
were designated as "appropriate for outreach" by their primary care providers received a letter
from their provider about the need to be screened and a brochure about colorectal cancer
screening. Patient navigators then called patients to discuss screening and to assist patients in
obtaining screening. Patients at a demographically similar control health center received usual care.
Results: Thirty-one percent of intervention patients were screened at six months, versus nine
percent of control patients (p < .001).
Conclusion:  A patient navigator-based intervention, in combination with a letter from the
patient's primary care provider, was associated with an increased rate of colorectal cancer
screening at one health center as compared to a demographically similar control health center. Our
study adds to an emerging literature supporting the use of patient navigators to increase colorectal
cancer screening in diverse populations served by urban health centers.
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Background
Colorectal cancer is the second leading cause of cancer
death in the United States (US). In 2008, an estimated
148,810 people will be diagnosed with colorectal cancer,
and it is estimated that 49,960 will die of the disease. [1]
Current guidelines from the U.S. Preventive Services Task
Force [2] recommend screening individuals age 50 until
age 75 with one of the following tests: flexible sigmoidos-
copy every 5 years, colonoscopy every 10 years, or fecal
occult blood test (FOBT) every year. Despite the availabil-
ity of these effective screening tests [3-7] a large propor-
tion of Americans are still not being screened. [8-10]
Patients at greatest risk of not being screened include
racial and ethnic minorities,[10,11] patients with Medic-
aid or no health insurance,[8,12,13] those who are for-
eign born,[12,14] and patients with low socioeconomic
status [15] – groups that are commonly served by commu-
nity health centers.[8,16]
In a prior qualitative study of community health centers at
Cambridge Health Alliance that included patients from
Brazil, Portugal, the Azores, Cape Verde and Haiti, [17]
large immigrant groups in Massachusetts and elsewhere in
the US, we found that the following factors prevented
patients from being screened for colorectal cancer: 1) lack
of trust in doctors; 2) lack of symptoms; 3) lack of a doc-
tor's recommendation for screening and 4) fatalistic views
about cancer. Few physicians were aware that lack of trust
and fatalistic beliefs about cancer were barriers to screen-
ing for their patients. Physicians typically cited comorbid
medical conditions and numerous psychosocial stressors
as the main reasons why patients did not receive colorec-
tal cancer screening.
We used these findings to inform the development of a
patient navigator-based intervention. Patient navigators
are people selected from the community who are trained
to guide patients through the health care system to receive
appropriate services.[18] A type of care management,
patient navigation encompasses a wide range of advocacy
and coordination activities.[19] Most published research
on patient navigators has focused on breast and cervical
cancer screening, showing that navigation increases the
rate of patient completion of screening and follow-up
evaluation.[20,21]
Several studies, all conducted in New York City, have
shown that patient navigation can increase rates of color-
ectal cancer screening among urban minority
patients.[18,21-24] Our study adds to the existing litera-
ture by including Haitian Creole and Portuguese-speaking
patients, and patients in a geographic area other than New
York. We report the results of a pilot study to assess the
feasibility of using patient navigators to increase rates of
colorectal cancer screening among community health
center patients in Massachusetts.
Methods
Study setting and sample
Cambridge Health Alliance (CHA) is a Primary Care Prac-
tice-Based Research Network (PBRN)[25] including 15
community health centers. The health centers predomi-
nantly serve a multi-cultural, low-income population in
Cambridge, Somerville, and Everett, MA. We selected one
health center to pilot-test the intervention, and a demo-
graphically similar health center to serve as the control
health center. The CHA institutional review board
approved the study protocol. The institutional review
board provided a waiver of informed consent, since the
study was promoting an established screening standard
and primary care providers (PCPs) were able to identify
patients who were not appropriate to contact.
Using an electronic clinical data system (Meditech), we
identified patients aged 52–80 who appeared to be
unscreened for colorectal cancer. We included patients age
75–80 because at the time of the study, age 80 was consid-
ered to be the upper age limit of screening by the U.S. Pre-
ventive Services Task Force. We chose to begin at age 52
instead of age 50 (the age at which guidelines suggest that
screening begin), because we sought consistency with the
Healthcare Effectiveness Data and Information Set
(HEDIS) measure on colorectal cancer screening. [26,27]
The unscreened patient report used in our study also
served as the basis for our ambulatory quality improve-
ment colorectal cancer screening measure. We based eligi-
bility for colorectal cancer screening on a modified
version of the most recent HEDIS measure. US health
plans utilize HEDIS measures to assess performance on
important dimensions of care, including cancer screening.
We modified the denominator of the measure to include
any patient aged 52–80 who had one visit to a primary
care physician in a community health center in each of the
two previous years. The numerator included any patient
who received colonoscopy in the past 10 years, sig-
moidoscopy or barium enema in the past five years, or
fecal occult blood testing (FOBT) during the prior year.
Using this definition, 47% of eligible patients in our net-
work of community health centers received colorectal can-
cer screening in the year 2006. Since the data report did
not capture tests performed outside of Cambridge Health
Alliance, or FOBT cards that were not billed, we suspect
that the true screening rate was higher than 47%.
We limited our intervention group to patients who spoke
English, Portuguese, Spanish or Haitian Creole and who
received care at one center in Somerville, MA. We
excluded patients of two primary care providers (PCPs) at
the intervention center: one PCP who was a study investi-BMC Family Practice 2009, 10:37 http://www.biomedcentral.com/1471-2296/10/37
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gator (KEL), and one PCP who was leaving the health
center at the time of the study. The control group con-
sisted of a random sample of similarly defined patients
(speaking the same languages and unscreened for colorec-
tal cancer based on the abovementioned definition) at
another health center in Somerville.
Study Procedures
Because the electronic data system did not capture diag-
nostic tests performed outside of the health center net-
work, one investigator (KEL) reviewed the medical records
of all patients at both the intervention and control health
centers who appeared unscreened in the data report to
confirm that they were, in fact, unscreened. After review-
ing 196 medical records at the intervention center and
191 medical records at the intervention center, we identi-
fied 93 intervention patients and 90 control patients who
had not received colorectal cancer screening according to
the criteria specified above.
We asked each of the eight PCPs at the intervention center
to review their list of unscreened patients and to identify
any patient who they deemed inappropriate for telephone
outreach, based on the following criteria: 1) patient has a
medical contraindication to screening or a short life
expectancy so that they do not warrant screening[25] 2)
the patient will be out of the country continuously for at
least three months during the period of navigation 3) the
patient had severe cognitive or mental impairment, and
no one who can be identified as a caretaker or proxy and
4) other reason as designated by the PCP.
Of the 93 unscreened patients, PCPs deemed 38 (41%) to
be inappropriate for outreach for the following reasons:
patient has a long history of refusing screening (n = 16),
patient with medical comorbidity (n = 7), gastrointestinal
symptoms or gastrointestinal workup in progress (n = 6),
mental illness or substance abuse (n = 5), other reasons (n
= 4; patient uninsured, out of the country, or moving).
Fourteen of the 38 patients deemed ineligible for outreach
were uninsured.
Intervention
The remaining 55 patients were eligible to receive the
intervention. We sent letters by first-class mail, signed by
each PCP, notifying patients that they were overdue for
colorectal cancer screening, and that a patient navigator
would be calling them. The mailing also included a color-
ectal cancer screening brochure designed by the Harvard
Center for Cancer Prevention and the Massachusetts
Colorectal Cancer Working Group ("Take Control: Get
Tested for Colorectal Cancer"). The brochure, written at a
sixth-grade reading level, offered patient-oriented infor-
mation about the reasons for screening, the different
screening modalities, and lifestyle changes to lower risk of
colorectal cancer. We sent brochures to patients in Eng-
lish, Portuguese, Spanish, or French (for Haitian Creole-
speaking patients).
The study patients were also eligible to receive navigation
from navigators speaking English and Spanish, Portu-
guese, and Haitian Creole, respectively. The navigators
were based in the hospital's Department of Community
Affairs; they did not have a presence at the intervention
health center. The navigator who worked with English and
Spanish-speaking patients was originally from Nicaragua,
had completed college, and had extensive experience
doing community health outreach. She was also a trained
certified nurse's assistant (CNA). The Portuguese-speaking
navigator had been a masters-level clinical psychologist in
Brazil, and was an experienced community health worker.
The Haitian navigator was also an experienced commu-
nity health worker, and worked as a medical assistant in a
local community health center. All of the navigators were
women, and were age 47, 42, and 37, respectively.
The navigators attended a two day training program in
October 2007. The training program included lectures
and interactive role plays about the following subjects: 1)
the principles of motivational interviewing [28] 2) color-
ectal cancer and how patients can be screened for it; 3)
logistics ("how-to," pros, and cons) of FOBT cards and
colonoscopy 4) prevention of colorectal cancer (including
prevention by removal of adenomas) 5) use of open vs.
closed questions, reflective listening, and summarizing; 6)
assessment of patient's readiness for screening and 7)
approaches for patients who refuse screening (pre-con-
templation), are willing to think about it (contempla-
tion), or are ready to act (action).[28] We chose to frame
the intervention around a "stages of change" model as
other cancer prevention studies have successfully
employed this model.[29]
During the study implementation, the project manager
(who also attended the training sessions) audited between
one and five patient calls by each navigator for adherence
to a calling script and for motivational interviewing tech-
niques. The patient navigators and the project manager
also met on a weekly basis to discuss challenges arising
during the outreach calls and to review the use of motiva-
tional interviewing techniques.
Over a three week period in October 2007, the patient
navigators made between 8 and 11 attempts to call each
patient on different days (weekdays and weekends) and at
different times (morning, afternoon, and evening) until
they reached a patient. The navigators also left at least two
messages for the patient, either on the answering machine
or with a family member.BMC Family Practice 2009, 10:37 http://www.biomedcentral.com/1471-2296/10/37
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Once the navigator reached a patient, the navigator dis-
cussed the need for colorectal cancer screening with the
patient, the screening options of colonoscopy vs. FOBT
cards, and the advantages and disadvantages of each test.
The navigators did not discuss other screening test
options, such as flexible sigmoidoscopy and barium
enema, since such options were not routinely offered to
patients by their PCPs.
If a patient was interested in completing FOBT cards, the
navigator reviewed the FOBT instructions with the patient
and mailed FOBT cards and illustrated instructions to
patients by first-class mail. The navigator also offered to
review the FOBT instructions with the patient over the
phone as soon as the patient received the FOBT cards. If a
patient did not return the FOBT cards within four weeks,
the navigator called the patient to provide support and to
address barriers to completion.
For patients who were interested in pursuing colonos-
copy, the navigators described the test in detail and the
project manager contacted the patient's PCP to arrange a
colonoscopy referral. Based on the patient's comorbid
medical conditions, the PCP either referred the patient
directly for colonoscopy or for a routine appointment
with a gastroenterologist to discuss colonoscopy. Patients
with any of the following conditions were not eligible for
direct referral: sleep apnea, obesity (BMI > 30), previous
history of anesthesia problems, congestive heart failure,
presence of an automatic implanted cardiac defibrillator,
renal failure (as defined by the PCP), and warfarin use for
any reason. For patients referred directly to colonoscopy,
a registered nurse (LV) called the patient, educated him/
her about the procedure and the bowel preparation, and
mailed instructions for the bowel preparation to the
patient. The patient did not require a medical visit prior to
the colonoscopy procedure. The gastroenterology office
placed reminder calls to all patients one day prior to their
procedure. Due to medico-legal concerns, the navigators
did not escort patients home after the colonoscopy. In the
event that a patient did not have someone to escort them
home, the navigators advised them to complete FOBT
cards instead.
At the control health center, patients eligible for colorectal
cancer screening received usual care. PCPs offered patients
screening on an ad-hoc basis during primary care visits.
Unlike the PCPs at the intervention center, the PCPs at the
control center did not review their lists of unscreened
patients. At both health centers, PCPs had some decision
support to promote colorectal cancer screening in the Epic
electronic medical record. The electronic record includes a
health maintenance grid which flags age-appropriate
patients who have not received colorectal cancer screen-
ing. The PCPs at the control health center could also refer
patients directly for colonoscopy at the time of the study,
but they did not have access to patient navigators to advise
patients on screening options or to assist them in com-
pleting the test.
Measures
The primary outcome of the study was completion of
colorectal cancer screening at six months. While the inter-
vention focused on the completion of colonoscopy or a
set of three FOBT cards from home, patients who com-
pleted any of the following during the study period were
considered to have been screened: colonoscopy, sig-
moidoscopy or barium enema, or FOBT cards. One of the
investigators (KEL) conducted a non-blinded chart review
to determine completion of colorectal cancer screening
tests.
Process Evaluation
During the study, the navigators maintained paper
records in which they documented details of their interac-
tions with patients, including the patients' readiness to be
screened, barriers to screening, and actions that were
taken to promote screening. The project manager entered
these data into a Microsoft Access database.
Statistical Methods
We included all patients at the intervention center in an
intention-to-treat analysis, regardless of whether they
were designated by their PCP to receive navigation, or
whether a navigator successfully reached the patient.
Using the χ2 test, we compared screening rates at six
months among intervention patients and control
patients. We chose to analyze the data at six months
because the wait for a screening colonoscopy at the time
of the study was on the order of weeks, and we assumed
that patients would have had sufficient time to complete
their colonoscopy during the six-month period.
Results
Table 1 shows the demographic characteristics of the
intervention and control center patients. The patients at
both centers were of similar age, race (note that race data
were missing for 7 persons), and insurance status. Of
those patients who had insurance, the majority at both
sites had Medicaid or free care (66% at the intervention
center and 51% at the control center). At the time of the
study, after being determined ineligible for other payment
options, Massachusetts residents were able to apply for
help paying for health center bills from the Massachusetts
uncompensated (free) care pool. The non-English speak-
ing patients at both sites were mostly Portuguese speak-
ing, with small numbers of Spanish and Haitian Creole
speaking patients.BMC Family Practice 2009, 10:37 http://www.biomedcentral.com/1471-2296/10/37
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Screening Outcomes
Table 2 shows the main study results. Patients in the inter-
vention center were much more likely to be screened
within six months than patients in the control group
(31% vs. 9%, χ2 p < .001). Due to small numbers we did
not present P values for comparisons between the differ-
ent types of screening (FOBT and colonoscopy). Three of
the 38 patients (8%) whom PCPs at the intervention site
deemed ineligible for outreach were screened at six
months (Figure 1).
Of the 29 patients screened at the intervention site, 16
completed FOBT cards, and 13 completed colonoscopy.
Among patients who completed FOBT cards, all tests were
negative. Of those patients who completed colonoscopy,
three had high-risk lesions; one patient had a tubulovil-
lous adenoma, one patient had four tubular adenomas,
and another had a 35 mm. tubular adenoma. A fourth
patient had two small tubular adenomas. Among the
eight patients screened at the control site, seven com-
pleted FOBT cards and one completed colonoscopy. Three
patients at the control site had positive FOBT results, but
only one of these patients completed a follow-up colon-
oscopy within six months.
Process Outcomes
Of the 55 patients who were offered navigation, the
patient navigators were unable to contact 14 (25%) after
between eight and eleven attempted telephone calls. Two
of these 14 patients (14%) were screened at six months,
while 24 of the 41 patients (59%) whom the navigators
were able to contact were screened at six months. For
patients reached by the navigator, the median number of
contacts was five (range 1–16). Patients received, on aver-
age, about four hours of telephone outreach. Patients who
received more contact (eight or more calls) were no more
likely to be screened than those who received less contact
(fewer than eight calls).
In their discussions with patients, the navigators learned
that many patients had not been screened because their
PCP had not taken enough time to educate them about
colorectal cancer screening. For example, one patient
stated, "my doctor asked me if I wanted to have it (colon-
Table 1: Community Health Center Patient Characteristics
Variable Intervention Control Chi-square p-value
n = 93 N = 90
Female (%) 63.4 75.6 .08
Mean Age (SD) 60.6 (6.6) 60.9 (7.1) .54
Race (%)
White 67.0 71.8 .50
Non-White 33.0 28.2
Insurance coverage (%)
No coverage 24.7 17.8 .25
Coverage 75.3 82.2
Language used in visit (%)
English 51.6 53.3 .82
Non-English 48.4 46.7
Flow diagram of intervention patients Figure 1
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oscopy) done, and I said no and that was it." The patient
noted that the PCP did not explore her reasons for declin-
ing screening. In addition, patients related not being able
to take time off from work to undergo colonoscopy.
Discussion
We found that a patient navigator-based intervention was
associated with an increased rate of colorectal cancer
screening at one health center as compared to a demo-
graphically similar control health center. Almost one-
third of intervention patients were screened at six months
versus nine percent of control patients. Our study adds to
an emerging literature supporting the use of patient navi-
gators to increase colorectal cancer screening in diverse
populations served by urban health centers.[19,22-24]
While our intervention was effective, it did not achieve the
screening rates observed in other studies. For example,
studies by Chen et al[18] and Christie et al[24] found that
over 50% of navigated patients completed colonoscopy.
These studies offered patient navigation only after a
patient had been referred for screening colonoscopy by
their PCP, which may explain their higher screening rates.
In addition, these studies excluded patients who required
a gastrointestinal clinic visit for pre-screening evaluation.
Jandorf et al[22] also achieved higher screening rates, in
both the intervention and control groups. It is possible
that the higher screening rates observed in all of these nav-
igation studies could partially be attributed to secular
trends. In New York City, where all three of these studies
were conducted, 1.25 million people were screened in
2007, up from 826,000 in 2003, with the biggest rates of
increase in minority communities.[30]
Our study was limited by the fact that only 41 (44%) of
93 unscreened patients at the intervention health center
were actually contacted by a patient navigator. The PCPs
at the intervention site identified 38 patients (41%) as
inappropriate for outreach. While some of the PCPs rea-
sons for excluding patients were legitimate, such as medi-
cal comorbidity, gastrointestinal symptoms or
gastrointestinal workup in progress, and mental illness or
substance abuse (our navigators were not trained to deal
with these special populations), some of the patients who
were excluded may have been good candidates for patient
navigation services. Such patients included those with a
long history of refusing screening and the uninsured. By
excluding these patients, we may have underestimated the
potential impact of patient navigation. Our study is also
limited by small sample size, which precluded us from
examining the individual effects of different components
of the intervention (letter versus navigation) and from
performing exploratory subgroup analyses.
Unlike prior studies of patient navigation, which included
mostly Hispanic and African American patients, our study
included immigrants from Brazil, Portugal, the Azores,
and Haiti. Our inability to contact a substantial propor-
tion (25%) of patients, which decreased the effectiveness
of the intervention, may be due to the fact that many
patients travel back and forth to their country of origin.
The PCPs at the intervention site were often unaware of
their patients' migratory patterns, and hence did not
exclude such patients from being outreached. These
patients also experience housing instability.
Unmeasured differences between the two health centers
could account for the differential screening rates. In addi-
tion, the PCPs at the control center did not have an oppor-
tunity to identify patients whom they deemed
inappropriate for screening. We attempted to account for
this difference by including all of the intervention center
patients in an intent-to-treat analysis. A further potential
source of bias is the fact that our qualitative study of bar-
riers to colorectal cancer screening [17] included one PCP
from the intervention site, and no PCPs from the control
site. We doubt that a one-hour interview conducted with
a PCP in 2005 would have significantly affected his color-
ectal cancer screening practices.
Table 2: Colorectal Cancer Screening Results
Variable Intervention Control Chi-square p-value
n = 93 n = 90
(%) (%)
Screened for colorectal cancer at 6 months 31.2 8.9 .0002
Screened by FOBT 17.2 7.8 *
Positive tests 0 3.3 *
Screened by colonoscopy 14.0 1.1 *
Adenomas 4.3 0 *BMC Family Practice 2009, 10:37 http://www.biomedcentral.com/1471-2296/10/37
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Conclusion
This study supports the feasibility and effectiveness of a
patient navigator intervention to increase colorectal can-
cer screening rates in a community health center serving
ethnically and linguistically diverse patients. Future stud-
ies will need to examine the cost-effectiveness of such an
intervention, and a randomized trial would confirm the
effectiveness of patient navigation for immigrant groups
who have not been previously studied.
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